Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Browse Lab Results > 2020-0003

Trial Summary

About CDAS Project, PI, Publications: Serum levels of per- and polyfluorinated substances and risks of non-Hodgkin lymphoma and thyroid cancer

Datasets

Site: Lymphoid

Inclusion Criteria:

  • No Rare Cancers
  • Remove Hema Cases not of Interest
  • Has Serum
  • Has 250ul Pre-DX Serum (Eligible)
  • Matched at a 2-1 Ratio for Thyroid and a 1-1 Ratio For Hematopoietic (Selected)

Matching Factors:

  • Gender
  • Race (W/B/O)
  • Center for Hema match
  • Grouped study year of material (T0, T1/T2, T4/T5)
  • Calendar Year of Draw +/- 1 year
  • Age at Draw +/- 3 years

Match Ratio: 2-1 for Thyroid; 1-1 for Hematopoietic

Match Technique: Frequency matching only non-cases as controls.

Additional Matching Comments: The Hema match was done first and then the thyroid match was done targeting controls selected for the hema cases.

Analytes:

  • PFDA
  • PFHpA
  • PFHpS
  • PFHxA
  • PFHxS
  • PFNA
  • PFOA
  • PFOS branched
  • PFOS linear
  • PFOS total
  • PFUnA

Number of Cases: 894

Number of Controls: 761